Enfusion Investor Presentation Deck

Reconciliations ($ in thousands) Net income Adjustments: Interest expense Income tax Depreciation and amortization Payments for management incentive awards Adjusted EBITDA Net income margin Adjusted EBITDA margin enfusion $ Year Ended December 31, 2020 4,061 1,662 433 2,291 16,860 25,307 5.1% 31.8% $ 2019 12,656 724 486 1,157 6,086 21,109 21.4% 35.8% $ $ Six Months Ended June 30, 2021 8,360 2,802 551 1,672 13,385 16.5% 26.3% $ $ PROPRIETARY AND CONFIDENTIAL ©2021 ENFUSION. ALL RIGHTS RESERVED. 2020 10,667 728 429 1,011 12,835 28.7% 34.6% 39

View entire presentation